Impaired neutralizing antibody response to COVID-19 mRNA vaccines in cancer patients

Impaired neutralizing antibody response to COVID-19 mRNA vaccines in cancer patients

Abstract There is currently a critical need to determine the efficacy of SARS-CoV-2 vaccination for immunocompromised patients. In this study, we determined the neutralizing antibody response in 160 cancer patients diagnosed with chronic lymphocytic leukemia (CLL), lung cancer, breast cancer, and va...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Cong Zeng, John P. Evans, Sarah Reisinger, Jennifer Woyach, Christina Liscynesky, Zeinab El Boghdadly, Mark P. Rubinstein, Karthik Chakravarthy, Linda Saif, Eugene M. Oltz, Richard J. Gumina, Peter G. Shields, Zihai Li, Shan-Lu Liu
Format: article
Langue:EN
Publié: BMC 2021
Sujets:
Biotechnology
TP248.13-248.65
Biology (General)
QH301-705.5
Biochemistry
QD415-436
Accès en ligne:https://doaj.org/article/b0b75e1c41084268a96830ebeb2c2906
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/b0b75e1c41084268a96830ebeb2c2906

Documents similaires